These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11240646)

  • 41. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
    Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP
    J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women: a Korean Gynecologic Oncology Group Study.
    Lee KH; Lee IH; Kim BG; Nam JH; Kim WK; Kang SB; Ryu SY; Cho CH; Choi HS; Kim KT;
    Int J Gynecol Cancer; 2009 Jan; 19(1):84-7. PubMed ID: 19258947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ovarian sertoli-leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients.
    Akman L; Ertas IE; Gokcu M; Terek MC; Sanci M; Sanli UA; Zekioglu O; Ozsaran AA
    J Cancer Res Ther; 2016; 12(1):290-4. PubMed ID: 27072253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Childhood malignant ovarian germ cell tumors: a monoinstitutional experience.
    Terenziani M; Massimino M; Casanova M; Cefalo G; Ferrari A; Luksch R; Spreafico F; Polastri D; Fontanelli R; Piva L; Fossati-Bellani F
    Gynecol Oncol; 2001 Jun; 81(3):436-40. PubMed ID: 11371135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival and reproductive function after treatment of malignant germ cell ovarian tumors.
    Zanetta G; Bonazzi C; Cantù M; Binidagger S; Locatelli A; Bratina G; Mangioni C
    J Clin Oncol; 2001 Feb; 19(4):1015-20. PubMed ID: 11181664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pure pediatric ovarian immature teratomas: The French experience.
    Pavone R; Dijoud F; Galmiche L; Ro V; Hameury F; Sarnacki S; Orbach D; Briandet C; Pasquet M; Bertrand A; Fresneau B; Faure-Conter C
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28186. PubMed ID: 31981415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surveillance policy for stage I ovarian germ cell tumors.
    Dark GG; Bower M; Newlands ES; Paradinas F; Rustin GJ
    J Clin Oncol; 1997 Feb; 15(2):620-4. PubMed ID: 9053485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bleomycin, etoposide and cisplatinum (BEP) chemotherapy for metastatic germ cell tumours: treatment outcomes at UKM medical centre, Malaysia.
    Azrif M; Leong YK; Aslan NM; Fong KV; Ismail F
    Asian Pac J Cancer Prev; 2012; 13(6):2467-71. PubMed ID: 22938405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neoadjuvant Bleomycin, Etoposide, and Cisplatin (BEP) Chemotherapy in the Treatment of Extensively Advanced Yolk Sac Tumors: A Single Center Experience.
    Zhang GY; Zhang R; Wu LY; Li B; Li SM
    Int J Gynecol Cancer; 2018 May; 28(4):713-720. PubMed ID: 29461339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study.
    Billmire D; Vinocur C; Rescorla F; Cushing B; London W; Schlatter M; Davis M; Giller R; Lauer S; Olson T;
    J Pediatr Surg; 2004 Mar; 39(3):424-9; discussion 424-9. PubMed ID: 15017564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of malignant ovarian germ-cell tumors treated in Chiang Mai University Hospital over a nine year period.
    Neeyalavira V; Suprasert P
    Asian Pac J Cancer Prev; 2014; 15(12):4909-13. PubMed ID: 24998562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgery for germ cell tumors.
    Sagae S; Kudo R
    Semin Surg Oncol; 2000; 19(1):76-81. PubMed ID: 10883028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
    Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
    Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PVB chemotherapy in patients with recurrent or advanced dysgerminoma: a Phase II study of the EORTC Gynaecological Cancer Cooperative Group.
    Pawinski A; Favalli G; Ploch E; Sahmoud T; van Oosterom AT; Pecorelli S
    Clin Oncol (R Coll Radiol); 1998; 10(5):301-5. PubMed ID: 9848330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
    Culine S; Théodore C; Bekradda M; Farhat F; Terrier-Lacombe MJ; Droz JP
    Am J Clin Oncol; 1997 Apr; 20(2):184-8. PubMed ID: 9124197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrospective Analysis of Pure Ovarian Immature Teratoma in Patients Aged 15-39 Years: A Turkish Multicenter Study.
    Yüksel D; Ayhan S; Korkmaz V; Çakır C; Kılıç Ç; Akgor U; Özgül N; Kılıç F; Ersak B; Esen S; Kuru O; Uncu D; Gökcü M; Özdal B; Gültekin M; Salman MC; Boran N; Toptaş T; Üreyen I; Taşcı T; Kimyon Cömert G; Türkmen O; Moraloğlu Tekin Ö; Engin Üstün Y; Turan T
    J Adolesc Young Adult Oncol; 2021 Dec; 10(6):697-702. PubMed ID: 33296263
    [No Abstract]   [Full Text] [Related]  

  • 60. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.